Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
The Key Accounts Manager will be responsible for developing and executing an ethical strategy to drive disease awareness and enhance partnerships between Corcept and pre-specified tertiary centers specializing in the management of cardio-metabolic diseases and/or hypercortisolism/Cushing syndrome (CS). Target physicians within these accounts would include but are not limited to, endocrinologists, neurosurgeons, endocrine surgeons, and interventional radiologists. Other key staff involved with the management and care of patients suffering from CS within these institutions would also constitute targets for further disease education.
Responsibilities:
- Develop and execute an ethical individualized strategy to drive market development/disease awareness for key tertiary centers
- Always lead with a patient-focused approach aligned to current CS guidelines and approved supporting data
- Educate target physicians within key tertiary centers on the latest data and developments in the field of hypercortisolism
- Regularly attend Endocrinology grand rounds sessions, conferences, and other relevant meetings
- Partner with Endocrinology fellowship programs to establish advocates as new Endocrinologists enter clinical practice
- Bridge the gaps in communication regarding the broad spectrum of CS amongst various target physician specialties within key tertiary centers
- Identify current and future institutional key opinion leaders (KOLs) within the cardiometabolic, surgical, radiological, and other related disease spaces
- Function as liaison and collaborator within key tertiary centers and for KOLS in prespecified territory
- Collaborate with sales counterparts and appropriate internal stakeholders to drive market growth/development
- Operate within compliance guidelines at all times
Preferred Skills, Qualifications and Technical Proficiencies:
- Experience working in tertiary centers with a specialty in endocrinology, orphan disease or other specialized markets
- Experience working with regional- and national-level KOLs
- Demonstrated excellent communication skills including written, oral & presentation capabilities
- Strong clinical acumen
- Demonstrated patient-focused mindset and approach
- Required to travel by car and plane at least 80% of the time
- Must maintain a driving record in accordance with Corcept vehicle policy
Preferred Education and Experience:
- Bachelor's degree
- 5+ years of pharmaceutical or medical device sales experience
- 2+ years working with institutions
#LI-Remote
The pay range that the Company reasonably expects to pay for this position is $167,800 - $246,700; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol.
The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
.png)
